ATE296353T1 - Regulation des menschlichen alpha-1a-adrenergen rezeptor-ähnlichen g-protein gekoppelten rezeptors - Google Patents
Regulation des menschlichen alpha-1a-adrenergen rezeptor-ähnlichen g-protein gekoppelten rezeptorsInfo
- Publication number
- ATE296353T1 ATE296353T1 AT01949336T AT01949336T ATE296353T1 AT E296353 T1 ATE296353 T1 AT E296353T1 AT 01949336 T AT01949336 T AT 01949336T AT 01949336 T AT01949336 T AT 01949336T AT E296353 T1 ATE296353 T1 AT E296353T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- asthma
- reagents
- human
- regulation
- Prior art date
Links
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 3
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 2
- 230000001800 adrenalinergic effect Effects 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 206010007556 Cardiac failure acute Diseases 0.000 abstract 1
- 206010012218 Delirium Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000012661 Dyskinesia Diseases 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 208000036626 Mental retardation Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 208000010362 Protozoan Infections Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010046555 Urinary retention Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 208000028683 bipolar I disease Diseases 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 230000036543 hypotension Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20414500P | 2000-05-15 | 2000-05-15 | |
| US25050500P | 2000-12-04 | 2000-12-04 | |
| PCT/EP2001/005383 WO2001088126A2 (en) | 2000-05-15 | 2001-05-11 | REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE296353T1 true ATE296353T1 (de) | 2005-06-15 |
Family
ID=26899224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01949336T ATE296353T1 (de) | 2000-05-15 | 2001-05-11 | Regulation des menschlichen alpha-1a-adrenergen rezeptor-ähnlichen g-protein gekoppelten rezeptors |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1287137B1 (de) |
| AT (1) | ATE296353T1 (de) |
| AU (1) | AU7051901A (de) |
| DE (1) | DE60111045T2 (de) |
| DK (1) | DK1287137T3 (de) |
| ES (1) | ES2241842T3 (de) |
| WO (1) | WO2001088126A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002028901A2 (en) * | 2000-10-05 | 2002-04-11 | Millennium Pharmaceuticals, Inc. | Seven-transmembrane (7tm) receptors and uses thereof |
| WO2002059304A1 (fr) * | 2001-01-23 | 2002-08-01 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice couplee a une proteine g et adn correspondant |
| WO2002059151A2 (en) * | 2001-01-26 | 2002-08-01 | Pe Corporation (Ny) | Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| WO2005071105A1 (fr) * | 2004-01-07 | 2005-08-04 | Fu Wai Hospital Chinese Academy Of Medical Sciences | Gene associe a l'hypertension essentielle, son procede de detection et ses utilisations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817477A (en) * | 1995-06-06 | 1998-10-06 | Human Genome Sciences, Inc. | Adrenergic receptor |
| US5891720A (en) * | 1997-04-17 | 1999-04-06 | Millennium Pharmaceuticals, Inc. | Isolated DNA encoding a novel human G-protein coupled receptor |
-
2001
- 2001-05-11 DK DK01949336T patent/DK1287137T3/da active
- 2001-05-11 AT AT01949336T patent/ATE296353T1/de not_active IP Right Cessation
- 2001-05-11 WO PCT/EP2001/005383 patent/WO2001088126A2/en not_active Ceased
- 2001-05-11 AU AU70519/01A patent/AU7051901A/en not_active Abandoned
- 2001-05-11 EP EP01949336A patent/EP1287137B1/de not_active Expired - Lifetime
- 2001-05-11 ES ES01949336T patent/ES2241842T3/es not_active Expired - Lifetime
- 2001-05-11 DE DE60111045T patent/DE60111045T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1287137T3 (da) | 2005-08-08 |
| ES2241842T3 (es) | 2005-11-01 |
| EP1287137A2 (de) | 2003-03-05 |
| DE60111045D1 (de) | 2005-06-30 |
| WO2001088126A2 (en) | 2001-11-22 |
| WO2001088126A3 (en) | 2002-07-25 |
| DE60111045T2 (de) | 2006-05-04 |
| AU7051901A (en) | 2001-11-26 |
| WO2001088126A8 (en) | 2003-06-12 |
| EP1287137B1 (de) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0867508A3 (de) | Geruchs Rezeptor von dem 7-Transmembran-Rezeptor Familie - OLRCC15 Rezeptor | |
| EP0875566A3 (de) | Neuartiger G-Protein gekoppelter Rezeptor | |
| EP0893498A3 (de) | cDNS Klon die für einen humanen 7-Transmembranrezeptor kodiert | |
| EP0875565A3 (de) | Neuartiger G-Protein gekoppelter Rezeptor (HFGAN72Y) | |
| EP0834563A3 (de) | Menschlicher transmembraner Rezeptor der Chemokinrezeptor-Familie, auch Strl-33 genannt | |
| EP0848060A3 (de) | Humane 11CB Splice-Varianten | |
| EP0899332A3 (de) | G-Protein gekoppelter Rezeptor HFIAO41 | |
| EP0892051A3 (de) | CDNA Klon Heoad54 der für einen menschlichen 7-Transmembranrezeptur kodiert | |
| WO2001094385A8 (en) | Human hm74-like g protein coupled receptor | |
| EP0885960A3 (de) | Protein G-gekoppelter Rezeptor (H7TBA62) | |
| WO2001077320A3 (en) | Regulation of human hm74-like g protein coupled receptor | |
| DE60116515D1 (de) | Regulierung des menschlichen p2y1-ähnlichen g-protein gekoppelten rezeptors | |
| ATE296353T1 (de) | Regulation des menschlichen alpha-1a-adrenergen rezeptor-ähnlichen g-protein gekoppelten rezeptors | |
| EP0881289A3 (de) | 7TM Receptor (H2CAA71) | |
| WO2001070814A3 (en) | Regulation of human rta-like g protein-coupled receptor | |
| WO2001068702A3 (en) | Regulation of human g protein-coupled receptor | |
| WO2001068842A3 (en) | Regulation of human p2y-like gpcr protein | |
| WO2001070971A3 (en) | Regulation of human mas oncogene-related g protein-coupled receptor | |
| WO2001004139A3 (en) | Human axor29 receptor | |
| EP0878479A3 (de) | Protein G-gekoppelter Rezeptor (HOFNH30) | |
| WO2001068701A3 (en) | Regulation of human seven transmembrane - like g protein - coupled receptor (7tm-gpcr) | |
| EP0894854A3 (de) | Neuen Splice-Varianten von dem Epstein-Barr Virus-induzierten G-Protein gekoppelter Rezeptor | |
| EP0878542A3 (de) | CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert | |
| EP0853125A3 (de) | cDNS Klon HNFJD15 der für einen menschlichen 7-Transmembranrezeptur kodiert | |
| EP0884387A3 (de) | Menschlicher 7-Transmembran-Rezeptor HLWAR77 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1287137 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |